Beranda › Asma › California › San Jose
Uji klinis Asma di San Jose, CA
5 studi untuk Asma mencari peserta di lokasi sekitar San Jose (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
Menerima pesertaFase 2
- Research Site, San Jose
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
Menerima pesertaFase 2
- Enveda Investigative Site, San Jose
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
Menerima pesertaFase 2
- Allergy and Asthma Associates of Santa Clara Valley Research Center, San Jose
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
Menerima pesertaFase 3
- Teva Investigational Site 12064, San Jose
A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
Menerima pesertaFase 2
- Research site, San Jose
Uji klinis Asma di kota lain
- Miami, FL12 studi
- New York City, NY11 studi
- Boston, MA11 studi
- Oklahoma City, OK10 studi
- Durham, NC10 studi
- Dallas, TX10 studi
- Washington, DC9 studi
- The Bronx, NY9 studi
- Kansas City, KS8 studi
- Houston, TX8 studi
- St. Louis, MO7 studi
- Pittsburgh, PA7 studi
Studi lain di San Jose
- Kanker Paru9 studi
- Kanker Paru Non-Sel Kecil7 studi
- Gangguan Depresi Mayor7 studi
- Kanker Prostat6 studi
- Kanker (semua jenis)6 studi
- Kanker Payudara6 studi
- Kanker Ovarium4 studi
- Adenokarsinoma Esofagus3 studi
- Depresi3 studi
- Kanker Ginjal (Karsinoma Sel Renal)3 studi
- Kanker Pankreas3 studi
- Melanoma3 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.